Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Kronos Bio Inc
(NQ:
KRON
)
0.9928
+0.0323 (+3.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Kronos Bio Inc
< Previous
1
2
3
Next >
Stocks That Hit 52-Week Lows On Monday
November 28, 2022
On Monday, 79 companies reached new 52-week lows.
Via
Benzinga
Kronos Bio Announces Participation in Upcoming Investor Conferences
November 22, 2022
From
Kronos Bio, Inc.
Via
GlobeNewswire
Expert Ratings for Kronos Bio
November 18, 2022
Via
Benzinga
Kronos Bio Starts Dosing In Early-Stage Leukemia Study With Next-Gen SYK Inhibitor
August 22, 2022
Via
Benzinga
The Week In Charts: Millon-Dollar Trade Missed?
August 13, 2022
Recent big winners and how we picked them, nuances of trend trading, and answering your questions.
Via
Talk Markets
Palo Alto To Surge Around 38%? Plus This Analyst Predicts $65 For Helmerich & Payne
November 18, 2022
Barclays raised the price target on Palo Alto Networks, Inc. (NASDAQ: PANW) from $200 to $215. Barclays analyst Saket Kalia maintained an Overweight rating on the stock. Palo Alto Networks shares fell...
Via
Benzinga
Kronos Bio Reports Recent Business Progress and Third-Quarter 2022 Financial Results
November 08, 2022
From
Kronos Bio, Inc.
Via
GlobeNewswire
Kronos Bio Announces Prioritization of Clinical Portfolio to Focus on Lanraplenib and KB-0742
November 08, 2022
From
Kronos Bio, Inc.
Via
GlobeNewswire
Kronos Bio to Present Preclinical Data for KB-0742, an Oral CDK9 Inhibitor Targeting MYC-amplified Cancers, in Pediatric Cancer Models in Poster Presentation at EORTC-NCI-AACR 2022
October 12, 2022
Company Plans to Provide Update and Recommended Phase 2 Dose from Ongoing KB-0742 Phase 1/2 Clinical Trial in Q4 2022
From
Kronos Bio, Inc.
Via
GlobeNewswire
Recap: Kronos Bio Q4 Earnings
February 25, 2022
Kronos Bio (NASDAQ:KRON) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement....
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
February 04, 2022
On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low...
Via
Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 22, 2022
Via
Benzinga
Kronos Bio Shares Fall After Initial-Stage Blood Cancer Study Takes-off
August 22, 2022
Kronos Bio (NASDAQ: KRON) has initiated patient dosing in a Phase 1b/2 clinical trial of lanraplenib in combination with gilteritinib in patients with relapsed/refractory FLT3-mutated acute myeloid...
Via
Benzinga
The Week In Charts: The Trading Secret That's Really Not A Secret
August 20, 2022
Discussing the secret that's not, really; also recent winners, dealing with open profit drawdowns and more.
Via
Talk Markets
12 Health Care Stocks Moving In Thursday's Intraday Session
July 28, 2022
Via
Benzinga
7 Nasdaq Stocks to Buy on the Dip
July 25, 2022
If you want to maximize your return potential and can handle some heat, here are compelling Nasdaq stocks to buy on the dip.
Via
InvestorPlace
38 Stocks Moving In Friday's Mid-Day Session
May 20, 2022
Gainers Leju Holdings Limited (NYSE: LEJU) surged 27.8% to $4.0413.
Via
Benzinga
66 Biggest Movers From Friday
May 23, 2022
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year.
Via
Benzinga
20 Stocks Moving in Friday's Pre-Market Session
May 20, 2022
Gainers Exicure, Inc. (NASDAQ: XCUR) shares rose 28.1% to $0.1550 in pre-market trading. Exicure said in Form4 filing a director bought 1,472,126 shares at average price of $0.19 per share.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
April 21, 2022
On Thursday, 236 companies hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
February 02, 2022
During Wednesday's session, 18 companies made new 52-week lows. Noteable 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) is the largest company in terms of market...
Via
Benzinga
50 Biggest Movers From Yesterday
January 13, 2022
Gainers electroCore, Inc. (NASDAQ: ECOR) shares jumped 64% to settle at $0.88 on Wednesday after the company's gammaCore nVNS device received FDA Breakthrough Designation for...
Via
Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
August 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2021
June 24, 2021
Upgrades Zelman upgraded the previous rating for Armstrong World Industries Inc (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 27, 2021
Gainers Vaxart (NASDAQ:VXRT) shares moved upwards by 53.38% to $9.29 during Tuesday's regular session. Vaxart's stock is trading at a volume of 115.1 million...
Via
Benzinga
The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue
April 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.